Biologics Safety Testing Market Global Industry Growth Analysis 2021

1
Biologics Safety Testing Market, 2021 - 2027
Copyright Precision Business Insights
2
Market Overview
The global Biologics safety testing market was
valued at USD 2.9 Billion in 2020 and is
anticipated to grow at USD 6.21 Billion till 2027
recording a CAGR of 11.5. during the forecast
period 2021-2027. Biologics safety testing is
performed for the safety of the patient. Several
different tests like bioburden tests, sterility
tests, residual host contamination detection
tests and endotoxins test are used to perform
biological safety testing. In addition, the
report discusses the implications of COVID-19,
including the industry's initial response and
strategies for ensuring business continuity in
the coming years. View Detailed Report
Description
3
Market Segments
The global biologics safety testing market has
been fragmented based on 1. By Product
Reagents and Kits, Instruments, Services2. By
Test Type Sterility Tests, Bioburden Tests,
Endotoxin Tests, Residual Host Contamination
detection Tests, Cell Line Authentication and
Characterization Tests, Others3. By End User
Pharmaceutical Companies, Biotechnology
Companies 4. By Geography North America, Asia
Pacific, Europe, Middle East and Africa, Latin
America Request Sample Report
4
Key Players
Some of the major key players in the biologics
safety testing market areCharles River
Laboratories (U.S.), Pace Analytical Services
Inc. (U.S.) Thermo Fisher Scientific Inc.
(U.S.) WuXi Apptec (China) Sartorius AG
(Germany) Toxikon Corporation (U.S.) Cytovance
Biologics, Inc. (U.S.) SGS SA (Switzerland) Reque
st Sample Report
5
Europe Office Precision Business Insights, Kemp
House, 152 160 City Road, London EC1V
2NX Asia-Pacific Office Precision Business
Insights, 202, RVS Sree Homes, Opp Bharat
Petroleum Pump,Khanamet Road, Hitech City,
Hyderabad, India 500084 Email sales_at_precisionbu
sinessinsights.com Toll Free 1-866-598-1553